AR039662A1 - Preparaciones para administracion topica de sustancias que tienen actividad antiandrogenica - Google Patents

Preparaciones para administracion topica de sustancias que tienen actividad antiandrogenica

Info

Publication number
AR039662A1
AR039662A1 ARP030101423A ARP030101423A AR039662A1 AR 039662 A1 AR039662 A1 AR 039662A1 AR P030101423 A ARP030101423 A AR P030101423A AR P030101423 A ARP030101423 A AR P030101423A AR 039662 A1 AR039662 A1 AR 039662A1
Authority
AR
Argentina
Prior art keywords
preparations
substances
topical administration
compound
formula
Prior art date
Application number
ARP030101423A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of AR039662A1 publication Critical patent/AR039662A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una preparación que comprende al menos una forma e nanopartículas lípidas o una nanoemulsión que comprende al menos un compuesto de la fórmula (1), y / o una forma estereoisómera del compuesto de la fórmula (1) y / o una sal fisiológicamente tolerada del compuesto de la fórmula (1), en el que R1 es alquilo C5-17, o alquenilo C5-17, es adecuada para el tratamiento de la alopecia androgénica, del hirsutismo, es decir, impedir el crecimiento no deseado del cabello, y para el tratamiento de la seborrea y el acné y además se puede emplear en cosméticos
ARP030101423A 2002-04-27 2003-04-24 Preparaciones para administracion topica de sustancias que tienen actividad antiandrogenica AR039662A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10218963A DE10218963A1 (de) 2002-04-27 2002-04-27 Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen

Publications (1)

Publication Number Publication Date
AR039662A1 true AR039662A1 (es) 2005-03-02

Family

ID=29264882

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101423A AR039662A1 (es) 2002-04-27 2003-04-24 Preparaciones para administracion topica de sustancias que tienen actividad antiandrogenica

Country Status (17)

Country Link
EP (1) EP1501806B1 (es)
JP (1) JP4633459B2 (es)
AR (1) AR039662A1 (es)
AT (1) ATE321756T1 (es)
AU (1) AU2003229658B2 (es)
BR (1) BRPI0309579B8 (es)
CA (1) CA2483786C (es)
DE (2) DE10218963A1 (es)
DK (1) DK1501806T3 (es)
ES (1) ES2256735T3 (es)
IL (1) IL164814A0 (es)
MX (1) MXPA04009571A (es)
MY (1) MY129714A (es)
PE (1) PE20031044A1 (es)
PT (1) PT1501806E (es)
TW (1) TWI285637B (es)
WO (1) WO2003093243A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1634874A4 (en) 2003-06-12 2008-04-02 Chugai Pharmaceutical Co Ltd imidazolidine
WO2005060661A2 (en) 2003-12-19 2005-07-07 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies
CA2554696C (en) * 2004-02-13 2009-06-30 Warner-Lambert Company Llc Androgen receptor modulators
CN100475781C (zh) * 2004-02-13 2009-04-08 沃尼尔·朗伯有限责任公司 雄激素受体调节剂
US7718684B2 (en) 2004-02-24 2010-05-18 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
WO2005100305A1 (en) 2004-04-13 2005-10-27 Warner-Lambert Company Llc Androgen modulators
CA2562672C (en) 2004-04-22 2009-09-29 Warner-Lambert Company Llc 4-cyano-phenoxy derivatives as androgen modulators
WO2006006065A1 (en) * 2004-07-08 2006-01-19 Warner-Lambert Company Llc Androgen modulators
BRPI0514706A (pt) * 2004-08-31 2008-06-24 Warner Lambert Co moduladores de androgênio
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
PT3412290T (pt) 2006-03-27 2021-04-19 Univ California Modulador do recetor de androgénios para o tratamento de cancro da próstata e doenças associadas ao recetor de androgénios
JP5350217B2 (ja) 2006-03-29 2013-11-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ジアリールチオヒダントイン化合物
CA2966280A1 (en) 2007-10-26 2009-04-30 The Regents Of The University Of California Diarylhydantoin compounds
EA028869B1 (ru) 2010-02-16 2018-01-31 Арагон Фармасьютикалс, Инк. Модуляторы рецептора андрогенов и их применение
RU2503446C2 (ru) * 2012-02-07 2014-01-10 Алексей Валентинович Одинцов Средство для роста волос (варианты) и способ лечения облысения
NZ745682A (en) 2012-09-26 2019-09-27 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
PL222631B1 (pl) * 2012-11-14 2016-08-31 Gdański Univ Medyczny Kompozycja farmaceutyczna zawierająca roksytromycynę, sposób jej wytwarzania oraz zastosowanie medyczne tej kompozycji i produkt leczniczy zawierający kompozycję
WO2014078929A1 (pt) * 2012-11-26 2014-05-30 Universidade Federal De Minas Gerais - Ufmg Formulações tópicas para a prevenção e tratamento da alopecia e para inibição do crescimento de pêlos
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
CN103965112A (zh) * 2014-05-13 2014-08-06 上海孚一生物科技有限公司 一种具有抗雄激素活性的化合物、制备方法及其应用
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
CN111479560A (zh) 2017-10-16 2020-07-31 阿拉贡药品公司 用于治疗非转移性去势难治性前列腺癌的抗雄激素

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693461B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2716110B1 (fr) * 1994-02-16 1996-04-05 Roussel Uclaf Compositions cosmétiques ou pharmaceutiques comprenant des liposomes.
AU726572B2 (en) * 1994-02-16 2000-11-09 Aventis Pharma S.A. Cosmetics or pharmaceutical compositions consisting of liposomes

Also Published As

Publication number Publication date
WO2003093243A1 (de) 2003-11-13
BR0309579B1 (pt) 2014-10-07
MY129714A (en) 2007-04-30
BRPI0309579B8 (pt) 2021-05-25
EP1501806B1 (de) 2006-03-29
PT1501806E (pt) 2006-06-30
DE50302818D1 (de) 2006-05-18
ES2256735T3 (es) 2006-07-16
JP2005535584A (ja) 2005-11-24
CA2483786A1 (en) 2003-11-13
AU2003229658A1 (en) 2003-11-17
PE20031044A1 (es) 2004-02-09
MXPA04009571A (es) 2005-01-11
CA2483786C (en) 2011-08-09
TW200407312A (en) 2004-05-16
JP4633459B2 (ja) 2011-02-16
ATE321756T1 (de) 2006-04-15
EP1501806A1 (de) 2005-02-02
DK1501806T3 (da) 2006-05-29
DE10218963A1 (de) 2003-11-20
TWI285637B (en) 2007-08-21
BR0309579A (pt) 2005-03-01
AU2003229658B2 (en) 2010-07-29
IL164814A0 (en) 2005-12-18

Similar Documents

Publication Publication Date Title
AR039662A1 (es) Preparaciones para administracion topica de sustancias que tienen actividad antiandrogenica
JP4152987B2 (ja) 哺乳類の発毛の調節
US8632759B2 (en) Hair restorer
AU646069B2 (en) Stimulation of hair growth with potassium channel openers and 5alpha-reductase inhibitors
US20090214628A1 (en) Methods and compositions for treatment of skin
ATE281143T1 (de) Verwendung einer biochinone enthaltenden wirkstoffkombination zur herstellung kosmetischer oder dermatologischer zubereitungen zur behandlung und prophylaxe von kopfschuppen
EP1948236A2 (en) Methods and compositions for treatment of skin
YU58394A (en) Use of inhibitors of 5-alfa reductaze in the production of medicament used for the treatment of androgen alopecia
Bellad et al. Development ofcosmeceuticals
PT1123082E (pt) Preparacoes para aplicacao topica de substancias de actividade antiandrogenica
EP3129026A1 (en) Hair enhancing formulation
US20080026018A1 (en) Administration of coumarin, butylated hydroxyanisole and ethoxyquine for the treatment of canities
JPS61183206A (ja) 化粧料
KR930703252A (ko) 항알레르기성 화장품 또는 약학적, 특히 피부학적 조성물의 제조에 사용되는 쿠쿠르비틴의 용도 및 그의 사용방법
US20120258972A1 (en) Composition and Methods for Treating Hair Loss
EA032573B1 (ru) Композиция для осветления кожи, содержащая 4-гексилрезорцин и иломастат
Desai et al. Cysteamine: Clinical efficacy, safety and tolerability versus best-in-class treatments for melasma
Jobanputra et al. Eflornithine
BR112017013142B1 (pt) Preparação dermatológica e/ou cosmética, uso de uma preparação dermatológica e/ou cosmética e processo para a produção de uma preparação dermatológica e/ou cosmética
WO2024056568A1 (en) Skin depigmentation composition and use thereof
JPWO2013180229A1 (ja) 育毛用組成物
ITMI942645A1 (it) Uso di derivati guanidin-imidazolici per coadiuvare la stimolazione della crescita dei capelli.
JPH11279032A (ja) フケ抑制剤組成物
JPH11322546A (ja) 頭皮頭髪用化粧料
JPS62265213A (ja) 養毛剤

Legal Events

Date Code Title Description
FG Grant, registration